Mark Aspinall O’Dea

Mark Aspinall O’Dea

Company: Retrogenix

Job title: EMEA Business Development Manager


Screening CAR T Cells for Target Specificity Using Human Cell Microarray Technology 5:15 pm

Optimization of the human cell microarray technology for off-target screening of whole engineered CAR T cells, in addition to antibodies and ScFvs An efficient approach for specificity screening of novel cell therapies to support safety assessment and provide key data prior to IND submissionsRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.